RU2014144001A - Мягкие жевательные фармацевтические продукты - Google Patents
Мягкие жевательные фармацевтические продукты Download PDFInfo
- Publication number
- RU2014144001A RU2014144001A RU2014144001A RU2014144001A RU2014144001A RU 2014144001 A RU2014144001 A RU 2014144001A RU 2014144001 A RU2014144001 A RU 2014144001A RU 2014144001 A RU2014144001 A RU 2014144001A RU 2014144001 A RU2014144001 A RU 2014144001A
- Authority
- RU
- Russia
- Prior art keywords
- active pharmaceutical
- product
- pharmaceutical ingredient
- optionally
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
1. Мягкий жевательный ветеринарный фармацевтический продукт, содержащий в качестве ингредиентов:- памовую кислоту или ее фармацевтически приемлемую соль, при условии, что памовая кислота или ее фармацевтически приемлемая соль не является активным фармацевтическим ингредиентом,- один или несколько активных фармацевтических ингредиентов,- жидкий компонент,- формообразующий агент, и- необязательно, один или несколько эксципиентов.2. Продукт по п. 1, где продукт содержит памоат натрия.3. Продукт по п. 1 или 2, в котором количество памовой кислоты или ее фармацевтически приемлемой соли составляет от 1,5 до 30% (масс./масс.).4. Мягкий жевательный ветеринарный фармацевтический продукт, содержащий в качестве ингредиентов:- памоатную соль активного фармацевтического ингредиента, при условии, что такой активный фармацевтический ингредиент не является памоатом пирантела или памоатом оксантела,- необязательно, один или несколько других активных фармацевтических ингредиентов,- жидкий компонент,- формообразующий агент,- необязательно, памовую кислоту или ее фармацевтически приемлемую соль, и- необязательно, один или несколько эксципиентов.5. Продукт по любому из пп. 1, 2 или 4, дополнительно содержащий один или несколько следующих эксципиентов:- наполнитель,- стабилизирующий компонент,- ароматизирующий компонент, и/или- сахарный компонент.6. Продукт по п. 1, в котором активный фармацевтический ингредиент представляет собой изоксазолиновое соединение формулы (I):где R= галоген, CF, OCF, CN,n = целое число от 0 до 3, предпочтительно 1, 2 или 3,R= C-С-галогеналкил, предпочтительно CFили CFCl,Т = 5- или 6-членное кольцо, которое необязательно замещено одним или несколькими радикалами Y,Y = метил, галогенметил, гал
Claims (20)
1. Мягкий жевательный ветеринарный фармацевтический продукт, содержащий в качестве ингредиентов:
- памовую кислоту или ее фармацевтически приемлемую соль, при условии, что памовая кислота или ее фармацевтически приемлемая соль не является активным фармацевтическим ингредиентом,
- один или несколько активных фармацевтических ингредиентов,
- жидкий компонент,
- формообразующий агент, и
- необязательно, один или несколько эксципиентов.
2. Продукт по п. 1, где продукт содержит памоат натрия.
3. Продукт по п. 1 или 2, в котором количество памовой кислоты или ее фармацевтически приемлемой соли составляет от 1,5 до 30% (масс./масс.).
4. Мягкий жевательный ветеринарный фармацевтический продукт, содержащий в качестве ингредиентов:
- памоатную соль активного фармацевтического ингредиента, при условии, что такой активный фармацевтический ингредиент не является памоатом пирантела или памоатом оксантела,
- необязательно, один или несколько других активных фармацевтических ингредиентов,
- жидкий компонент,
- формообразующий агент,
- необязательно, памовую кислоту или ее фармацевтически приемлемую соль, и
- необязательно, один или несколько эксципиентов.
5. Продукт по любому из пп. 1, 2 или 4, дополнительно содержащий один или несколько следующих эксципиентов:
- наполнитель,
- стабилизирующий компонент,
- ароматизирующий компонент, и/или
- сахарный компонент.
6. Продукт по п. 1, в котором активный фармацевтический ингредиент представляет собой изоксазолиновое соединение формулы (I):
где R1 = галоген, CF3, OCF3, CN,
n = целое число от 0 до 3, предпочтительно 1, 2 или 3,
R2 = C1-С3-галогеналкил, предпочтительно CF3 или CF2Cl,
Т = 5- или 6-членное кольцо, которое необязательно замещено одним или несколькими радикалами Y,
Y = метил, галогенметил, галоген, CN, NO2, NH2C=S, или два соседних радикала Y вместе образуют цепь, преимущественно 3- или 4-членную цепь;
Q = X-NR3R4 или 5-членное N-гетероарильное кольцо, которое необязательно замещено одним или несколькими радикалами;
X = СН2, СН(СН3), CH(CN), СО, CS,
R3 = водород, метил, галогенэтил, галогенпропил, галогенбутил, метоксиметил, метоксиэтил, галогенметоксиметил, этоксиметил, галогенэтоксиметил, пропоксиметил, этиламинокарбонилметил, этиламинокарбонилэтил, диметоксиэтил, пропиниламинокарбонилметил, N-фенил-N-метиламино, галогенэтиламинокарбонилметил, галогенэтиламинокарбонилэтил, тетрагидрофурил, метиламинокарбонилметил, (N,N-диметиламино)карбонилметил, пропиламинокарбонилметил, циклопропиламинокарбонилметил, пропениламинокарбонилметил, галогенэтиламинокарбонилциклопропил,
где ZA = водород, галоген, циано, галогенметил (CF3);
R4 = водород, этил, метоксиметил, галогенметоксиметил, этоксиметил, галогенэтоксиметил, пропоксиметил, метилкарбонил, этилкарбонил, пропилкарбонил, циклопропилкарбонил, метоксикарбонил, метоксиметилкарбонил, аминокарбонил, этиламинокарбонилметил, этиламинокарбонилэтил, диметоксиэтил, пропиниламинокарбонилметил, галогенэтиламинокарбонилметил, цианометиламинокарбонилметил или галогенэтиламинокарбонилэтил;
или R3 и R4 вместе образуют заместитель, выбранный из группы, состоящей из:
или его соль или сольват.
7. Продукт по п. 6, в котором активный фармацевтический ингредиент представляет собой 4-[5-(3,5-дихлорфенил)-5-трифторметил-4,5-дигидроизоксазол-3-ил]-2-метил-N-[(2,2,2-трифторэтилкарбомоил)метил]бензамид.
8. Продукт по п. 6, в котором активный фармацевтический ингредиент представляет собой 4-[5-[3-хлор-5-(трифторметил)фенил]-4,5-дигидро-5-(трифторметил)-3-изоксазолил]-N-[2-оксо-2-[(2,2,2-трифторэтил)амино]этил]-1-нафталинкарбоксамид.
9. Продукт по п. 6, в котором активный фармацевтический ингредиент представляет собой 4-[5-(3,5-дихлорфенил)-5(трифторметил)-4Н-изоксазол-3-ил]-2-метил-N-(триэтан-3-ил)бензамид.
10. Продукт по п. 6, в котором активный фармацевтический ингредиент представляет собой 5-[5-(3,5-дихлорфенил)-4,5-дигидро-5-(трифторметил)-3-изоксазолил]-3-метил-N-[2-оксо-2-[(2,2,2-трифторэтил)амино]этил]-2-тиофенкарбоксамид.
11. Продукт по п. 1, который содержит более чем один активный фармацевтический ингредиент.
12. Способ получения продукта по любому из пп. 1-11 в формующей машине, где способ включает стадии:
(a) смешивания ингредиентов в тестообразную массу,
(b) заполнения формы тестообразной массой, и
(c) удаления тестообразной массы из формы,
где на стадии смешивания а) памовую кислоту или ее фармацевтически приемлемую соль смешивают с другими ингредиентами.
13. Применение памовой кислоты или ее фармацевтически приемлемой соли в способе по п. 12 для увеличения смазывающей способности продукта по пп. 1-11 при заполнении пресс-формы тестообразной массой или при удалении тестообразной массы из пресс-формы формы, или в обоих случаях.
14. Применение мягкого жевательного ветеринарного фармацевтического продукта по любому из пп. 1-11 в производстве лекарственного средства для борьбы с заражением животного паразитарными насекомыми, акаридами или нематодами.
15. Мягкая жевательная ветеринарная фармацевтическая композиция, содержащая изоксазолиновое соединение формулы (I), как определено в пп. 6, 7, 8, 9 или 10, для применения в способе борьбы с заражением животного паразитарными насекомыми, акаридами или нематодами.
16. Композиция по п. 15, в котором жидкий компонент содержит одно или более масло, один или более неводный растворитель и один или более увлажнитель.
17. Композиция по п. 15, в котором жидкий компонент содержит одно или более масло, один или более неводный растворитель и глицерин.
18. Композиция по п. 15, в котором жидкий компонент содержит соевое масло, один или более неводный растворитель и увлажнитель.
19. Композиция по п. 15, в котором формообразующий агент содержит полиэтиленгликоль.
20. Продукт по п. 1, содержащий соевое масло, глицерин и полиэтиленгликоль 3350.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12163198 | 2012-04-04 | ||
EP12163198.0 | 2012-04-04 | ||
US201361782434P | 2013-03-14 | 2013-03-14 | |
US61/782,434 | 2013-03-14 | ||
PCT/EP2013/056987 WO2013150052A1 (en) | 2012-04-04 | 2013-04-03 | Soft chewable pharmaceutical products |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017133665A Division RU2765231C2 (ru) | 2012-04-04 | 2013-04-03 | Мягкие жевательные фармацевтические продукты |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2014144001A true RU2014144001A (ru) | 2016-05-27 |
RU2632965C2 RU2632965C2 (ru) | 2017-10-11 |
Family
ID=49300034
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017133665A RU2765231C2 (ru) | 2012-04-04 | 2013-04-03 | Мягкие жевательные фармацевтические продукты |
RU2014144001A RU2632965C2 (ru) | 2012-04-04 | 2013-04-03 | Мягкие жевательные фармацевтические продукты |
RU2014144360A RU2646483C2 (ru) | 2012-04-04 | 2013-04-03 | Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017133665A RU2765231C2 (ru) | 2012-04-04 | 2013-04-03 | Мягкие жевательные фармацевтические продукты |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014144360A RU2646483C2 (ru) | 2012-04-04 | 2013-04-03 | Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений |
Country Status (13)
Country | Link |
---|---|
US (15) | US20150057321A1 (ru) |
EP (2) | EP2833866B1 (ru) |
JP (2) | JP6148724B2 (ru) |
KR (1) | KR102077874B1 (ru) |
CN (4) | CN104203214B (ru) |
AU (7) | AU2013245011B2 (ru) |
BR (3) | BR122022008957B1 (ru) |
CA (2) | CA2869242C (ru) |
ES (1) | ES2633611T5 (ru) |
NZ (1) | NZ631100A (ru) |
RU (3) | RU2765231C2 (ru) |
WO (2) | WO2013150055A1 (ru) |
ZA (2) | ZA201406968B (ru) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230959B1 (hu) | 2012-02-06 | 2019-06-28 | Merial, Inc. | Szisztémás hatóanyagokat tartalmazó, parazitaellenes hatású, orális állatgyógyászati készítmények, eljárások és alkalmazásuk |
CN104203214B (zh) | 2012-04-04 | 2018-05-25 | 英特维特国际股份有限公司 | 软咀嚼药用产品 |
US9532946B2 (en) | 2012-11-20 | 2017-01-03 | Intervet Inc. | Manufacturing of semi-plastic pharmaceutical dosage units |
CA2932790C (en) | 2013-12-10 | 2021-10-12 | Intervet International B.V. | Antiparasitic use of isoxazoline compounds |
US10456358B2 (en) | 2013-12-20 | 2019-10-29 | Intervet Inc. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
PL3082806T3 (pl) * | 2013-12-20 | 2021-09-13 | Intervet International B.V. | Stosowanie pochodnych izoksazoliny w leczeniu i profilaktyce infestacji stawonogów u drobiu |
EP3215120A1 (en) * | 2014-11-03 | 2017-09-13 | Zoetis Services LLC | Palatable chewable veterinary composition |
EP4008329A1 (en) | 2014-12-22 | 2022-06-08 | Intervet International B.V. | Isoxazoline compounds for use in treating demodicosis |
UY36570A (es) | 2015-02-26 | 2016-10-31 | Merial Inc | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas |
UY37137A (es) | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
WO2018039508A1 (en) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
WO2018081733A1 (en) * | 2016-10-31 | 2018-05-03 | The California Institute For Biomedical Research | Methods and compositions for preventing vector-borne disease transmission |
CN110996920A (zh) | 2017-07-26 | 2020-04-10 | 太杰先软嚼有限责任公司 | 用于兽医应用的无淀粉软咀嚼物 |
WO2020051106A1 (en) * | 2018-09-05 | 2020-03-12 | Zoetis Services Llc | Palatable antiparasitic formulations |
WO2021013825A1 (en) * | 2019-07-22 | 2021-01-28 | Intervet International B.V. | Soft chewable veterinary dosage form |
EP4075981A1 (en) * | 2019-12-16 | 2022-10-26 | Intervet International B.V. | Composition for lice control |
AU2022232440A1 (en) * | 2021-03-11 | 2023-09-21 | In The Bowl Animal Health, Inc. | Oral canine feed and methods for controlling tick infestations in a canine |
EP4304356A1 (en) * | 2021-03-11 | 2024-01-17 | In the Bowl Animal Health, Inc. | Oral canine feed and methods for controlling flea infestations in a canine |
WO2022271937A2 (en) * | 2021-06-25 | 2022-12-29 | In The Bowl Animal Health, Inc. | Oral feline feed and methods for controlling flea infestations in a feline |
CN113476419A (zh) * | 2021-08-17 | 2021-10-08 | 江苏恒丰强生物技术有限公司 | 一种宠物用氟雷拉纳咀嚼片及其制备方法 |
WO2023086578A1 (en) * | 2021-11-11 | 2023-05-19 | Nutramax Laboratories, Inc. | Soft chew |
WO2023198476A1 (en) | 2022-04-15 | 2023-10-19 | Krka, D.D., Novo Mesto | Soft chewable veterinary dosage form |
CN117122571A (zh) * | 2022-05-20 | 2023-11-28 | 天津瑞普生物技术股份有限公司 | 一种抗寄生虫感染的口服药物制剂及其制备方法和应用 |
FR3138315A1 (fr) | 2022-07-27 | 2024-02-02 | Virbac | Produit à usage vétérinaire et procédé pour sa fabrication |
Family Cites Families (162)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB819681A (en) * | 1957-01-24 | 1959-09-09 | Wellcome Found | Improvements in and relating to quaternary ammonium compounds and the preparation thereof |
US3486186A (en) | 1967-05-08 | 1969-12-30 | Hollymatic Corp | Molding apparatus |
US3887964A (en) | 1972-01-24 | 1975-06-10 | Formax Inc | Food patty molding machine |
US3952478A (en) | 1974-10-10 | 1976-04-27 | Formax, Inc. | Vacuum sheet applicator |
US4054967A (en) | 1975-10-20 | 1977-10-25 | Formax, Inc. | Food patty molding machine |
US4284652A (en) | 1977-01-24 | 1981-08-18 | The Quaker Oats Company | Matrix, product therewith, and process |
US4182003A (en) | 1978-02-28 | 1980-01-08 | Formax, Inc. | Food patty molding machine |
US4338702A (en) | 1979-03-29 | 1982-07-13 | Holly Harry H | Apparatus for making a ground food patty |
US4334339A (en) | 1980-05-12 | 1982-06-15 | Hollymatic Corporation | Mold device with movable compression insert |
US4356595A (en) | 1980-11-07 | 1982-11-02 | Formax, Inc. | Method and apparatus for molding food patties |
US4327076A (en) | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
US4343068A (en) | 1981-01-19 | 1982-08-10 | Holly James A | Method and apparatus for unidirectional formation of a plug-formed patty with cleanout feature |
US4372008A (en) | 1981-04-23 | 1983-02-08 | Formax, Inc. | Food patty molding machine with multi-orifice fill passage and stripper plate |
US4393085A (en) | 1981-08-13 | 1983-07-12 | General Foods Corporation | Enzyme digestion for a dog food of improved palatability |
IE53474B1 (en) | 1981-09-17 | 1988-11-23 | Warner Lambert Co | A chewable comestible product and process for its production |
CH657506A5 (de) | 1981-12-10 | 1986-09-15 | Hollymatic Ag | Portioniermaschine zum fuellen von hohlraeumen mit verformbarem material und verwendung derselben. |
US4535505A (en) | 1982-11-23 | 1985-08-20 | Holly Systems, Inc. | Method and apparatus for forming a patty to accommodate tissue fiber flow |
US4608731A (en) | 1983-01-11 | 1986-09-02 | Holly Systems, Inc. | Food patty with improved void structure, shape, and strength and method and apparatus for forming said patty |
US4609543A (en) | 1983-11-14 | 1986-09-02 | Nabisco Brands, Inc. | Soft homogeneous antacid tablet |
US4597135A (en) | 1984-02-21 | 1986-07-01 | Holly Systems, Inc. | Food patty forming method and apparatus employing two or more agitator bars |
DE3406497A1 (de) | 1984-02-23 | 1985-09-05 | Mueller Bernhard Willi Werner | Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung |
US4768941A (en) | 1986-06-16 | 1988-09-06 | Hollymatic Corporation | Food patty and machine and method for making thereof |
US4697308A (en) | 1986-10-29 | 1987-10-06 | Formax, Inc. | Patty molding mechanism for whole fiber food product |
DE3636882C1 (de) | 1986-10-30 | 1988-05-19 | Schreiber Berthold | Vorrichtung zur feinblasigen Einleitung eines Gases in eine Fluessigkeit |
US4714620A (en) | 1986-12-12 | 1987-12-22 | Warner-Lambert Company | Soft, sugarless aerated confectionery composition |
US4780931A (en) | 1987-02-13 | 1988-11-01 | Marlen Research Corporation | Feeding device for patty forming machine |
US4821376A (en) | 1988-06-02 | 1989-04-18 | Formax, Inc. | Seal-off for food patty molding machine with multi-orifice fill passage and stripper plate |
US4997671A (en) | 1988-09-09 | 1991-03-05 | Nabisco Brands, Inc. | Chewy dog snacks |
US4872241A (en) | 1988-10-31 | 1989-10-10 | Formax, Inc. | Patty molding mechanism for fibrous food product |
US4935243A (en) | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
US5021025A (en) | 1989-09-12 | 1991-06-04 | Wagner Richard C | Method and machine for making food patties |
US4975039A (en) | 1989-09-18 | 1990-12-04 | Dare Gary L | Food molding and portioning apparatus |
US4996743A (en) | 1990-01-29 | 1991-03-05 | Formax, Inc. | Mold plate drive linkage |
US5022888A (en) | 1990-05-03 | 1991-06-11 | Formax, Inc. | Co-forming apparatus for food patty molding machine |
US5262167A (en) | 1990-12-20 | 1993-11-16 | Basf Corporation | Edible, non-baked low moisture cholestyramine composition |
US5380535A (en) | 1991-05-28 | 1995-01-10 | Geyer; Robert P. | Chewable drug-delivery compositions and methods for preparing the same |
JP2575325B2 (ja) | 1991-06-18 | 1997-01-22 | サクマ製菓株式会社 | キャンディ |
US5439924A (en) | 1991-12-23 | 1995-08-08 | Virbac, Inc. | Systemic control of parasites |
TW376319B (en) | 1993-04-28 | 1999-12-11 | Janssen Pharmaceutica Nv | Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine |
NZ285766A (en) | 1994-05-20 | 1997-09-22 | Janssen Pharmaceutica Nv | Anthelmintic compositions comprising flubendazole and brewers yeast |
US5637313A (en) | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
GB9508443D0 (en) | 1995-04-26 | 1995-06-14 | Gilbertson & Page | Biscuit for working racing or sporting dogs |
AUPN290395A0 (en) | 1995-05-10 | 1995-06-01 | Virbac (Australia) Pty Limited | Canine anthelmintic preparation |
US5578336A (en) | 1995-06-07 | 1996-11-26 | Monte; Woodrow C. | Confection carrier for vitamins, enzymes, phytochemicals and ailmentary vegetable compositions and method of making |
PE10898A1 (es) | 1995-06-13 | 1998-03-20 | American Home Prod | Formulaciones orales de etodolac s (+)- |
US5606889A (en) | 1995-09-19 | 1997-03-04 | G & H Technology, Inc. | Reusable initiator for use in triggering high-load actuators |
DE19628776A1 (de) | 1996-07-17 | 1998-01-22 | Bayer Ag | Oral applizierbare Granulate von Hexahydropyrazinderivaten |
US5730650A (en) | 1996-08-29 | 1998-03-24 | Progressive Technology Of Wisconsin, Inc. | Food patty molding machine |
US5655436A (en) | 1996-08-29 | 1997-08-12 | Progressive Technology Of Manitowoc, Inc. | Food patty molding machine |
US5827565A (en) | 1996-10-25 | 1998-10-27 | T.F.H. Publications, Inc. | Process for making an edible dog chew |
US6086940A (en) | 1996-10-25 | 2000-07-11 | T.F.H. Publications, Inc. | High starch content dog chew |
US6110521A (en) | 1996-10-25 | 2000-08-29 | T.F.H. Publications, Inc. | Wheat and casein dog chew with modifiable texture |
US6093427A (en) | 1997-09-03 | 2000-07-25 | T.F.H.Publications, Inc. | Vegetable-based dog chew |
US5753255A (en) | 1997-02-11 | 1998-05-19 | Chavkin; Leonard | Chewable molded tablet containing medicinally active substances |
US6723358B1 (en) | 1998-03-23 | 2004-04-20 | General Mills, Inc. | Encapsulation of components into edible products |
US6093441A (en) | 1998-07-15 | 2000-07-25 | Tfh Publications, Inc. | Heat modifiable peanut dog chew |
US6270790B1 (en) | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
US6387381B2 (en) | 1998-09-24 | 2002-05-14 | Ez-Med Company | Semi-moist oral delivery system |
US6060078A (en) | 1998-09-28 | 2000-05-09 | Sae Han Pharm Co., Ltd. | Chewable tablet and process for preparation thereof |
WO2000027849A2 (en) * | 1998-11-12 | 2000-05-18 | Merck & Co., Inc. | Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
US6159516A (en) | 1999-01-08 | 2000-12-12 | Tfh Publication, Inc. | Method of molding edible starch |
GB9902073D0 (en) | 1999-01-29 | 1999-03-24 | Nestle Sa | Chewy confectionery product |
US6500463B1 (en) | 1999-10-01 | 2002-12-31 | General Mills, Inc. | Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
EP1103181A1 (de) * | 1999-11-25 | 2001-05-30 | Novartis AG | Kombination der N-Phenyl-N'-Benzoyl Harnstoff Derivaten und Avermectin für Parasiten Kontrolle. |
US6340672B1 (en) * | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
US6787342B2 (en) | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
IT1317048B1 (it) | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie |
DE10031044A1 (de) | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere |
PL207109B1 (pl) | 2001-01-31 | 2010-11-30 | Bayer Cropscience Ag | Kompozycja herbicyd-odtrutka i sposób zwalczania chwastów w uprawach roślin użytkowych |
EP1247456A3 (en) | 2001-02-28 | 2003-12-10 | Pfizer Products Inc. | Palatable pharmaceutical compositions for companion animals |
GB0108485D0 (en) | 2001-04-04 | 2001-05-23 | Pfizer Ltd | Combination therapy |
EP1450860B1 (en) | 2001-10-05 | 2013-09-18 | Rubicon Scientific LLC | Animal feeds including actives |
AU2003262643A1 (en) | 2002-08-13 | 2004-02-25 | Intervet International B.V. | Compositions and process for delivering an additive |
US20040151759A1 (en) | 2002-08-16 | 2004-08-05 | Douglas Cleverly | Non-animal product containing veterinary formulations |
US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
GB0219639D0 (en) | 2002-08-22 | 2002-10-02 | Prestwick Scient Capital Inc | Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders |
US20040234579A1 (en) | 2003-05-22 | 2004-11-25 | Mark D. Finke, Inc. | Dietary supplements and methods of preparing and administering dietary supplements |
AR045142A1 (es) | 2003-07-30 | 2005-10-19 | Novartis Ag | Composicion veterinaria masticable ductil de buen sabor |
AU2008201605B2 (en) | 2003-07-30 | 2010-04-29 | Novartis Ag | Palatable ductile chewable veterinary composition |
US6987111B2 (en) | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
WO2005016356A1 (en) | 2003-08-08 | 2005-02-24 | The Hartz Mountain Corporation | Improved anthelmintic formulations |
US7396819B2 (en) | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
UA79571C2 (en) * | 2003-12-04 | 2007-06-25 | Basf Ag | Metod for the protection of seeds from soil pests comprising |
PE20051096A1 (es) | 2004-02-04 | 2006-01-23 | Novartis Ag | Formas de sal de 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil]-benzamida |
JP4883296B2 (ja) | 2004-03-05 | 2012-02-22 | 日産化学工業株式会社 | イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤 |
US20050226908A1 (en) | 2004-04-07 | 2005-10-13 | Akzo Nobel N.V. | Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use |
JP2008504229A (ja) † | 2004-04-09 | 2008-02-14 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 過剰体重および肥満症患者のための間欠的投薬レジメン |
US20050234119A1 (en) | 2004-04-16 | 2005-10-20 | Soll Mark D | Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals |
DE102004034043A1 (de) * | 2004-07-13 | 2006-02-09 | Krka Tovarna Zdravil, D.D. | Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält |
US7348027B2 (en) * | 2005-04-08 | 2008-03-25 | Bayer Healthcare Llc | Taste masked veterinary formulation |
US7838532B2 (en) * | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
EP1940380A2 (en) * | 2005-05-20 | 2008-07-09 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands |
CA2621228C (en) | 2005-09-02 | 2014-05-27 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and pesticide |
US20070128251A1 (en) | 2005-12-07 | 2007-06-07 | Piedmont Pharmaceuticals, Inc. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
US7955632B2 (en) | 2005-12-07 | 2011-06-07 | Bayer B.V. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
US20090143410A1 (en) | 2005-12-14 | 2009-06-04 | Kanu Maganbhai Patel | Isoxazolines for Controlling Invertebrate Pests |
TW200803740A (en) | 2005-12-16 | 2008-01-16 | Du Pont | 5-aryl isoxazolines for controlling invertebrate pests |
TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
WO2007105814A1 (ja) | 2006-03-10 | 2007-09-20 | Nissan Chemical Industries, Ltd. | 置換イソキサゾリン化合物及び有害生物防除剤 |
KR20090005201A (ko) | 2006-04-20 | 2009-01-12 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 무척추 해충 방제용 피라졸린 |
TWI342532B (en) * | 2006-07-10 | 2011-05-21 | Himax Tech Inc | Method for generating a gamma table |
JP2008044880A (ja) | 2006-08-15 | 2008-02-28 | Bayer Cropscience Ag | 殺虫性イソオキサゾリン類 |
NZ575435A (en) | 2006-09-07 | 2012-01-12 | Merial Ltd | Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations |
CN101190223A (zh) * | 2006-11-29 | 2008-06-04 | 天津市润拓生物技术有限公司 | 一种犬猫用双羟萘酸噻嘧啶咀嚼片 |
US20090281059A1 (en) | 2007-02-21 | 2009-11-12 | Robert Falotico | Coating for a medical device having an anti-thrombotic conjugate |
JP5206993B2 (ja) | 2007-03-07 | 2013-06-12 | 日産化学工業株式会社 | イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤 |
AU2008235089B8 (en) | 2007-04-10 | 2014-04-10 | Bayer Intellectual Property Gmbh | Insecticidal aryl isoxazoline derivatives |
JP2008260691A (ja) * | 2007-04-10 | 2008-10-30 | Bayer Cropscience Ag | 殺虫性アリールイソオキサゾリン誘導体 |
MX2009011852A (es) | 2007-05-03 | 2009-12-11 | Merial Ltd | Composiciones que comprenden compuestos macrolidos de alcoxieter de c-13 y compuestos de fenilpirazol. |
NZ580357A (en) * | 2007-05-07 | 2011-06-30 | Jurox Pty Ltd | Chewable gelatinised protein dosage form and process |
AU2008254279B2 (en) | 2007-05-15 | 2013-03-14 | Aventis Agriculture | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
US20080293645A1 (en) * | 2007-05-25 | 2008-11-27 | Schneider Lawrence F | Antiparasitic combination and method for treating domestic animals |
JP5473906B2 (ja) | 2007-06-13 | 2014-04-16 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | イソキサゾリン殺虫剤 |
TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
DK2957284T3 (en) * | 2007-06-27 | 2018-02-05 | Du Pont | PROCEDURE TO CHECK ANIMALS FOR ANIMALS |
EP2172448A4 (en) | 2007-06-29 | 2012-01-11 | Nissan Chemical Ind Ltd | SUBSTITUTED ISOXAZOLINE OR ENONOXINE COMPOUND AND PESTICIDES |
ITCL20070039A1 (it) | 2007-07-10 | 2009-01-11 | Michele Neri | Bombolo a pressione costante con tubo estrusore a proboscide e valvola dosatrice, agganciato ad una struttura su cui scorre, azionato da una fonte di pressione controllata, utilizzabile in particolare per la estrusione-lavorazione di tutte le paste: |
TWI556741B (zh) | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
WO2009035004A1 (ja) | 2007-09-10 | 2009-03-19 | Nissan Chemical Industries, Ltd. | 置換イソキサゾリン化合物および有害生物防除剤 |
ES2731881T3 (es) | 2007-09-25 | 2019-11-19 | Formulex Pharma Innovations Ltd | Composiciones que comprenden compuestos activos lipófilos y método para su preparación |
EP2193124B1 (en) | 2007-10-03 | 2012-12-19 | E. I. du Pont de Nemours and Company | Naphthalene isoxazoline compounds for control of invertebrate pests |
TWI411395B (zh) * | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
US8597688B2 (en) | 2008-07-09 | 2013-12-03 | Basf Se | Pesticidal mixtures comprising isoxazoline compounds II |
CN102149695B (zh) | 2008-07-09 | 2015-02-04 | 日产化学工业株式会社 | 异*唑啉取代的苯甲酰胺化合物的制造方法 |
CN102088856B (zh) * | 2008-07-09 | 2015-11-25 | 巴斯夫欧洲公司 | 包含异*唑啉化合物的杀虫活性混合物i |
JP2010026724A (ja) * | 2008-07-17 | 2010-02-04 | Fujitsu Ltd | Webページ提供装置、webページのランキング連動方法及びそのプログラム |
WO2010025998A1 (en) | 2008-09-04 | 2010-03-11 | Syngenta Participations Ag | Insecticidal compounds |
US9820977B2 (en) * | 2008-10-03 | 2017-11-21 | Bayer Healthcare Llc | Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
SG10201703698QA (en) | 2008-11-14 | 2017-06-29 | Merial Inc | Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds |
US8450357B2 (en) | 2008-11-19 | 2013-05-28 | Merial Limited | Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof |
WO2010065852A1 (en) | 2008-12-04 | 2010-06-10 | Merial Limited | Dimeric avermectin and milbemycin derivatives |
WO2010079077A1 (en) | 2008-12-18 | 2010-07-15 | Novartis Ag | Isoxazolines derivatives and their use as pesticide |
CN102256971B (zh) | 2008-12-19 | 2014-09-17 | 诺华股份有限公司 | 作为杀虫剂的异噁唑啉衍生物及其用途 |
KR20110099139A (ko) * | 2008-12-23 | 2011-09-06 | 바스프 에스이 | 동물 해충의 퇴치를 위한 치환된 아미딘 화합물 |
US20110288089A1 (en) | 2009-01-22 | 2011-11-24 | Syngenta Crop Protection Llc | Insecticidal compounds |
WO2010112545A1 (en) | 2009-04-01 | 2010-10-07 | Basf Se | Isoxazoline compounds for combating invertebrate pests |
NZ584629A (en) * | 2009-04-15 | 2010-12-24 | Jurox Pty Ltd | Anthelmintic formulation |
US9040583B2 (en) | 2009-07-22 | 2015-05-26 | Temple University-Of The Commonwealth System Of Higher Education | Treatment of disorders associated with G protein-coupled receptor 35 (GPR35) |
TWI487486B (zh) * | 2009-12-01 | 2015-06-11 | Syngenta Participations Ag | 以異唑啉衍生物為主之殺蟲化合物 |
ME02432B (me) | 2009-12-17 | 2016-09-20 | Merial Inc | Antiparazitska jedinjenja dihidroazola i kompozicije koje ih sadrže |
KR20120125332A (ko) | 2010-02-01 | 2012-11-14 | 바스프 에스이 | 동물 해충을 퇴치하기 위한 치환된 케톤계 이속사졸린 화합물 및 유도체 |
US20130085064A1 (en) | 2010-02-25 | 2013-04-04 | Syngenta Crop Protection Llc | Pesticidal mixtures containing isoxazoline derivatives and insecticide or nematoicidal biological agent |
CN102933563A (zh) | 2010-04-08 | 2013-02-13 | Ah美国42有限责任公司 | 作为杀虫剂和杀螨剂的取代的3,5-二苯基异噁唑啉衍生物 |
CN101919857B (zh) * | 2010-05-05 | 2012-05-30 | 四川宝盛康药业有限公司 | 一种复方阿苯达唑咀嚼片及其应用和制备方法 |
MA34247B1 (fr) | 2010-05-27 | 2013-05-02 | Du Pont | Forme cristalline du 4-[5-[3-chloro-5-(trifluorométhyl) phényl] -4,5-dihydro-5-(trifluorométhyl)-3-isoxazolyl]-n-[2-oxo-2-[(2, 2,2-trifluoroéthyl) amino] éthyl]-1-naphtalènecarboxamide |
US20130261069A1 (en) | 2010-06-09 | 2013-10-03 | Syngenta Crop Protection Llc | Pesticidal mixtures comprising isoxazoline derivatives |
US20130210623A1 (en) | 2010-06-09 | 2013-08-15 | Syngenta Crop Protection Llc | Pesticidal mixtures including isoxazoline derivatives |
WO2011154434A2 (en) | 2010-06-09 | 2011-12-15 | Syngenta Participations Ag | Pesticidal mixtures including isoxazoline derivatives |
UY33403A (es) | 2010-06-17 | 2011-12-30 | Novartis Ag | Compuestos orgánicos con novedosas isoxazolinas, sus n-óxidos, s-óxidos y sales |
DK178277B1 (da) | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazolinforbindelser til bekæmpelse af fiskelus |
CA2804147A1 (en) | 2010-06-30 | 2012-01-05 | Upsher-Smith Laboratories, Inc. | Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid |
WO2012007426A1 (en) | 2010-07-13 | 2012-01-19 | Basf Se | Azoline substituted isoxazoline benzamide compounds for combating animal pests |
JP2012046486A (ja) * | 2010-07-30 | 2012-03-08 | Sumitomo Chemical Co Ltd | 動物外部寄生虫防除剤 |
ES2682303T3 (es) | 2010-08-05 | 2018-09-19 | Zoetis Services Llc | Derivados de isoxazolina como agentes antiparasitarios |
AU2011306489B2 (en) | 2010-09-24 | 2015-11-05 | Zoetis Services Llc | Isoxazoline oximes as antiparasitic agents |
US9744127B2 (en) | 2010-10-12 | 2017-08-29 | Bayer Intellectual Property Gmbh | Non-starch based soft chewables |
DK2658542T3 (da) * | 2010-12-27 | 2022-03-28 | Intervet Int Bv | Topisk lokaliseret isoxazolinformulering |
KR20200019793A (ko) | 2011-09-12 | 2020-02-24 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 이속사졸 활성화제를 포함하는 구충 조성물, 이의 용도 및 구충 방법 |
AU2012344083A1 (en) * | 2011-11-29 | 2014-05-29 | Novartis Tiergesundheit Ag | Aryl derivatives for controlling ectoparasites |
HU230959B1 (hu) * | 2012-02-06 | 2019-06-28 | Merial, Inc. | Szisztémás hatóanyagokat tartalmazó, parazitaellenes hatású, orális állatgyógyászati készítmények, eljárások és alkalmazásuk |
CN104203214B (zh) * | 2012-04-04 | 2018-05-25 | 英特维特国际股份有限公司 | 软咀嚼药用产品 |
US9532946B2 (en) | 2012-11-20 | 2017-01-03 | Intervet Inc. | Manufacturing of semi-plastic pharmaceutical dosage units |
-
2013
- 2013-04-03 CN CN201380017735.9A patent/CN104203214B/zh active Active
- 2013-04-03 AU AU2013245011A patent/AU2013245011B2/en active Active
- 2013-04-03 US US14/390,040 patent/US20150057321A1/en not_active Abandoned
- 2013-04-03 CA CA2869242A patent/CA2869242C/en active Active
- 2013-04-03 NZ NZ631100A patent/NZ631100A/en unknown
- 2013-04-03 RU RU2017133665A patent/RU2765231C2/ru active
- 2013-04-03 ES ES13717212T patent/ES2633611T5/es active Active
- 2013-04-03 RU RU2014144001A patent/RU2632965C2/ru active
- 2013-04-03 WO PCT/EP2013/056992 patent/WO2013150055A1/en active Application Filing
- 2013-04-03 CN CN201380029186.7A patent/CN104334159A/zh active Pending
- 2013-04-03 KR KR1020147027827A patent/KR102077874B1/ko active IP Right Grant
- 2013-04-03 JP JP2015503865A patent/JP6148724B2/ja active Active
- 2013-04-03 CN CN201811130374.XA patent/CN109010296A/zh active Pending
- 2013-04-03 JP JP2015503867A patent/JP6088637B2/ja active Active
- 2013-04-03 EP EP13715654.3A patent/EP2833866B1/en active Active
- 2013-04-03 RU RU2014144360A patent/RU2646483C2/ru active
- 2013-04-03 BR BR122022008957-7A patent/BR122022008957B1/pt active IP Right Grant
- 2013-04-03 US US14/390,052 patent/US9770440B2/en active Active
- 2013-04-03 CN CN201810385736.3A patent/CN108685894B/zh active Active
- 2013-04-03 WO PCT/EP2013/056987 patent/WO2013150052A1/en active Application Filing
- 2013-04-03 CA CA2868381A patent/CA2868381C/en active Active
- 2013-04-03 EP EP13717212.8A patent/EP2833867B2/en active Active
- 2013-04-03 BR BR112014024832-0A patent/BR112014024832B1/pt active IP Right Grant
- 2013-04-03 AU AU2013245008A patent/AU2013245008B2/en active Active
- 2013-04-03 BR BR112014024833-8A patent/BR112014024833B1/pt active IP Right Grant
-
2014
- 2014-09-23 ZA ZA2014/06968A patent/ZA201406968B/en unknown
-
2016
- 2016-11-29 ZA ZA2016/08614A patent/ZA201608614B/en unknown
- 2016-12-21 US US15/386,100 patent/US20170100377A1/en not_active Abandoned
- 2016-12-23 US US15/390,244 patent/US20170105972A1/en not_active Abandoned
-
2017
- 2017-02-15 US US15/433,840 patent/US20170172986A1/en not_active Abandoned
- 2017-02-15 US US15/433,901 patent/US20170172918A1/en not_active Abandoned
- 2017-06-05 US US15/613,848 patent/US20170266165A1/en not_active Abandoned
- 2017-06-22 AU AU2017204246A patent/AU2017204246A1/en not_active Abandoned
- 2017-06-27 US US15/634,924 patent/US11337917B2/en active Active
- 2017-11-27 AU AU2017268487A patent/AU2017268487A1/en not_active Abandoned
-
2018
- 2018-05-17 US US15/982,904 patent/US20190117565A1/en not_active Abandoned
- 2018-05-17 US US15/982,879 patent/US20190117564A1/en not_active Abandoned
-
2019
- 2019-03-08 US US16/296,490 patent/US11285101B2/en active Active
- 2019-07-11 US US16/508,758 patent/US20200000718A1/en not_active Abandoned
- 2019-08-07 AU AU2019213359A patent/AU2019213359A1/en not_active Abandoned
- 2019-10-09 AU AU2019246812A patent/AU2019246812B2/en active Active
-
2021
- 2021-03-02 US US17/189,939 patent/US11712416B2/en active Active
- 2021-11-11 AU AU2021266292A patent/AU2021266292A1/en active Pending
-
2022
- 2022-01-25 US US17/648,841 patent/US20220142984A1/en active Pending
-
2023
- 2023-06-15 US US18/335,415 patent/US20230320981A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2014144001A (ru) | Мягкие жевательные фармацевтические продукты | |
JP2015514103A5 (ru) | ||
RU2015123737A (ru) | Производство полупластичных фармацевтических препаратов | |
JP2016507472A5 (ru) | ||
JP2015512435A5 (ru) | ||
JP2014504586A5 (ru) | ||
RU2016129474A (ru) | Изоксазолиновые композиции | |
RU2454411C2 (ru) | Производные хинолина | |
HRP20201745T1 (hr) | Paraziticidni pripravci koji sadrže djelatno sredstvo izoksazolina, postupak za njih i njihove uporabe | |
RU2013135415A (ru) | Изоксазолиновый состав, содержащий гликофурол для наружного и местного применения | |
JP2014506249A5 (ru) | ||
RU2016125306A (ru) | Новые пестицидные соединения и применения | |
RU2409576C2 (ru) | Системы, содержащие имидазольное кольцо с заместителями, и способы их получения | |
RU2018121905A (ru) | Паразитицидные пероральные ветеринарные композиции, включающие системно действующие активные агенты, способы и применение этих композиций и способов | |
RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
JP2016540809A5 (ru) | ||
HRP20170352T1 (hr) | Spojevi bis(fluroalkil)-1,4-benzodiazepinona kao notch inhibitori | |
CA2672373A1 (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
RU2007138978A (ru) | Гетероциклическое соединение | |
ES2670517T3 (es) | Compuesto de amida, un agente de control de plagas de artrópodos y un método para controlar las plagas de artrópodos | |
RU2014122035A (ru) | Соединения с нематоцидной активностью | |
JP2006506455A5 (ru) | ||
CY1111707T1 (el) | Παραγωγα toy 1,4 διαζαδικυκλο 3.2.1 οκτανοκαρβοξυαμιδιου, η παρασκευη τους και η θεραπευτικη εφαρμογη τους | |
RU2017117559A (ru) | Бензопроизводные с шестичленным кольцом в качестве ингибитора dpp-4 и их применение | |
JP2016539960A5 (ru) |